↓ Skip to main content

Possible serotonin syndrome with carbidopa–levodopa and linezolid

Overview of attention for article published in Journal of Clinical Pharmacy & Therapeutics, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

news
1 news outlet
twitter
6 X users
facebook
1 Facebook page

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Possible serotonin syndrome with carbidopa–levodopa and linezolid
Published in
Journal of Clinical Pharmacy & Therapeutics, January 2016
DOI 10.1111/jcpt.12352
Pubmed ID
Authors

N N Pettit, V Alonso, E Wojcik, E C Anyanwu, L Ebara, J-L Benoit

Abstract

Serotonin syndrome (SS) can occur when linezolid is combined with other serotonergic agents. We report a case of possible SS in an elderly patient receiving linezolid in combination with carbidopa-levodopa (CL). Although certain classes of agents are commonly reported as causing SS among patients receiving linezolid, there are no specific case reports detailing this reaction with CL. Linezolid combined with CL should generally be avoided; however, if linezolid must be used, discontinuation of other agents with serotonergic activity is recommended with careful monitoring for signs and symptoms of SS.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 5 17%
Student > Master 5 17%
Student > Bachelor 4 14%
Researcher 3 10%
Student > Doctoral Student 2 7%
Other 6 21%
Unknown 4 14%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 10 34%
Pharmacology, Toxicology and Pharmaceutical Science 4 14%
Nursing and Health Professions 2 7%
Agricultural and Biological Sciences 2 7%
Neuroscience 2 7%
Other 3 10%
Unknown 6 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2018.
All research outputs
#3,783,468
of 34,410,315 outputs
Outputs from Journal of Clinical Pharmacy & Therapeutics
#229
of 1,831 outputs
Outputs of similar age
#51,666
of 452,064 outputs
Outputs of similar age from Journal of Clinical Pharmacy & Therapeutics
#15
of 41 outputs
Altmetric has tracked 34,410,315 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,831 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,064 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.